glp-1 without diabetes medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1 -slash-risk-4-types-cancer-50-or-more-study GLP-1 Medications Infographic | Medidex

While individual risk can be modified by genetic influences, population risk and trends in obesity over time are predominantly driven by lifestyle trends related to cultural, community, and environmental factors

If you have a personal or family history of certain conditions, such as pancreatitis or medullary thyroid carcinoma, or are pregnant or breastfeeding, this treatment approach is not recommended for you

Last reviewed: July 12, 2026 Last updated: July 12, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

That triggers a prior authorization request for the Bridge program, which the provider must complete to certify that the individual is eligible